Phase 2 Arteriovenous Malformation Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
Arteriovenous Malformations
Centre Hospitalier Universitaire, Amiens50 enrolled13 locationsNCT02042326
Recruiting
Phase 2
A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
PI3K Gene MutationKRAS G12DVascular Anomalies+15 more
Murdoch Childrens Research Institute50 enrolled2 locationsNCT05983159
Recruiting
Phase 2
An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations
Brain Arteriovenous Malformations
Xuanwu Hospital, Beijing10 enrolled1 locationNCT06913725
Recruiting
Phase 2
Proton Radiotherapy for Primary Central Nervous System Tumours in Adults
Central Nervous System TumourArteriovenous Malformation
Uppsala University500 enrolled6 locationsNCT02797366